Fibrin patch - Ethicon/Omrix Biopharmaceuticals

Drug Profile

Fibrin patch - Ethicon/Omrix Biopharmaceuticals

Alternative Names: Evarrest; Fibrin pad; Fibrin sealant patch

Latest Information Update: 14 Mar 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ethicon; OMRIX Biopharmaceuticals
  • Class Antihaemorrhagics; Blood coagulation factors; Blood proteins; Serine endopeptidases
  • Mechanism of Action Fibrin stimulants; Thrombin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Surgical blood loss

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 05 Mar 2016 Phase-III clinical trials in Surgical blood loss (In adolescents, In children, In infants, In neonates) in England before March 2016 (Perilesional)
  • 05 Mar 2016 Efficacy data from a phase III trial in Surgical blood loss released by Ethicon
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top